Cargando…

Cost-utility analysis of the screening program for early oral cancer detection in Thailand

OBJECTIVE: To assess the cost-utility of an oral precancer screening program compared to a no-screening program in Thailand. MATERIALS AND METHODS: Markov models were performed to simulate costs and Quality Adjusted Life-Years (QALYs) of both the screening and no-screening programs in the Thai popul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumdee, Chutima, Kulpeng, Wantanee, Teerawattananon, Yot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264816/ https://www.ncbi.nlm.nih.gov/pubmed/30496214 http://dx.doi.org/10.1371/journal.pone.0207442

Ejemplares similares

Seasonal Influenza Vaccination for Children in Thailand: A Cost-Effectiveness Analysis
por: Meeyai, Aronrag, et al.
Publicado: (2015)

Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines
por: Haasis, Manuel Alexander, et al.
Publicado: (2015)

An economic analysis of chromosome testing in couples with children who have structural chromosome abnormalities
por: Thiboonboon, Kittiphong, et al.
Publicado: (2018)

Towards the introduction of pneumococcal conjugate vaccines in Bhutan: A cost-utility analysis to determine the optimal policy option
por: Dorji, Kinley, et al.
Publicado: (2018)

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
por: Thavorncharoensap, Montarat, et al.
Publicado: (2013)

Vaccination program in a resource-limited setting: A case study in the Philippines
por: Chootipongchaivat, Sarocha, et al.
Publicado: (2016)

Incorporating economies of scale in the cost estimation in economic evaluation of PCV and HPV vaccination programmes in the Philippines: a game changer?
por: Suwanthawornkul, Thanthima, et al.
Publicado: (2018)

Maternal and child health voucher scheme in Myanmar: a review of early stage implementation
por: Pilasant, Songyot, et al.
Publicado: (2016)

Mortality Attributable to Seasonal Influenza A and B Infections in Thailand, 2005–2009: A Longitudinal Study
por: Cooper, Ben S., et al.
Publicado: (2015)

Cost-utility analysis of adjuvant imatinib treatment in patients with high risk of recurrence after gastrointestinal stromal tumour (GIST) resection in Thailand
por: Bussabawalai, Thanaporn, et al.
Publicado: (2019)

Cost-Utility Analysis of Universal Maternal Pertussis Immunisation in Thailand: A Comparison of Two Model Structures
por: Botwright, Siobhan, et al.
Publicado: (2022)

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
por: Tantai, Narisa, et al.
Publicado: (2014)

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand
por: Pattanaphesaj, Juntana, et al.
Publicado: (2010)

Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections
por: Kulpeng, Wantanee, et al.
Publicado: (2013)

A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand
por: Leelahavarong, Pattara, et al.
Publicado: (2010)

The association between health costs and physical inactivity; analysis from the Physical Activity at Work study in Thailand
por: Akksilp, Katika, et al.
Publicado: (2023)

Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand
por: Leelahavarong, Pattara, et al.
Publicado: (2011)

The economic costs of alcohol consumption in Thailand, 2006
por: Thavorncharoensap, Montarat, et al.
Publicado: (2010)

Economic costs of obesity in Thailand: a retrospective cost-of-illness study
por: Pitayatienanan, Paiboon, et al.
Publicado: (2014)

Lessons drawn from research utilization in the maternal iodine supplementation policy development in Thailand
por: Tonmukayakul, Utsana, et al.
Publicado: (2012)

Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand
por: Yothasamut, Jomkwan, et al.
Publicado: (2010)

Assessing the Accuracy and Feasibility of a Refractive Error Screening Program Conducted by School Teachers in Pre-Primary and Primary Schools in Thailand
por: Teerawattananon, Kanlaya, et al.
Publicado: (2014)

A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines
por: Guerrero, Anna Melissa, et al.
Publicado: (2015)

Is it worth offering a routine laparoscopic cholecystectomy in developing countries? A Thailand case study
por: Teerawattananon, Yot, et al.
Publicado: (2005)

Multi-criteria decision analysis for setting priorities on HIV/AIDS interventions in Thailand
por: Youngkong, Sitaporn, et al.
Publicado: (2012)

The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand
por: Teerawattananon, Yot, et al.
Publicado: (2008)

Retrospective secondary data analysis to identify high-cost users in inpatient department of hospitals in Thailand, a middle-income country with universal healthcare coverage
por: Rattanavipapong, Waranya, et al.
Publicado: (2021)

A Data-Driven Analysis of the Economic Cost of Non-Pharmaceutical Interventions: A Cross-Country Comparison of Kenya, Singapore, and Thailand
por: Briones, Jamaica, et al.
Publicado: (2022)

Government use licenses in Thailand: an assessment of the health and economic impacts
por: Yamabhai, Inthira, et al.
Publicado: (2011)

Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6
por: Kapol, Nattiya, et al.
Publicado: (2016)

INADEQUATE PHYSICAL ACTIVITY ON HEALTHCARE EXPENDITURES AMONG MIDDLE AGE AND OLDER WORKING ADULTS IN THAILAND
por: Akksilp, Katika, et al.
Publicado: (2022)

Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment
por: Youngkong, Sitaporn, et al.
Publicado: (2010)

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand’s pharmaceutical benefit package
por: Anothaisintawee, Thunyarat, et al.
Publicado: (2012)

An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand
por: Thiboonboon, Kittiphong, et al.
Publicado: (2015)

Estimating the potential overdiagnosis and overtreatment of acute appendicitis in Thailand using a secondary data analysis of service utilization before, during and after the COVID-19 lockdown policy
por: Sukmanee, Jarawee, et al.
Publicado: (2022)

Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand
por: Rattanavipapong, Waranya, et al.
Publicado: (2023)

Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India
por: Chugh, Yashika, et al.
Publicado: (2021)

Advanced health biotechnologies in Thailand: redefining policy directions
por: Velasco, Román Pérez, et al.
Publicado: (2013)

Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations
por: Butani, Dimple, et al.
Publicado: (2023)

Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic
por: Wang, Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_equgnour8nols5d84svo270sur